Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Vertex Names Reshma Kewalramani to Succeed Leiden as CEO, Advance Therapies to 90% of CF Patients Vertex Names Reshma Kewalramani to Succeed Leiden as CEO, Advance Therapies to 90% of CF Patients Jul 29, 2019 07:00 am | Hal Foster Jeffrey Leiden, who in seven years has taken Vertex Pharmaceuticals to the cusp of developing treatments for about 90% of people with cystic fibrosis (CF), is exchanging his day-to-day leadership role as CEO for an elder statesman position. Leiden — who finished high school at 15, earned a PhD in virology from the University of Chicago […] The post Vertex Names Reshma Kewalramani to Succeed Leiden as CEO, Advance Therapies to 90% of CF Patients appeared first on Cystic Fibrosis News Today. Read More   Recent News Accepting the Bumps in the Road Arts, Education, Song, and Advocacy Programs Awarded 2019 Impact Grants by CFF Use Me for Something Good Mylan Given Rights to Market TOBI Solution and TOBI Podhaler in UK AR-501 Named Orphan Drug in EU as Possible Treatment for Chronic Lung Infections in CF